FDA Drug Recalls

Recalls / Class II

Class IID-0642-2022

Product

Alprazolam Tablets, USP 1mg, Generic for Xanax, Pkg Size: a) 30 tablets per bottle, NDC: 68788-6381-03, b) 60 tablets per bottle, NDC: 68788-6381-06, c) 90 tablets per bottle, NDC: 68788-6381-09, Mfg: Par Pharmaceutical.

Affected lot / code info
Lot #s: a) G2919M, I0619O, F1419J; b) H3019Q; c) F1219N, F1919D, H0219D, I0519R, J0319G, Exp. 03/31/2022.

Why it was recalled

CGMP deviations

Recalling firm

Firm
Preferred Pharmaceuticals, Inc.
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
1250 N Lakeview Ave Ste O, Anaheim, California 92807-1801

Distribution

Quantity
276 bottles
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2022-02-22
FDA classified
2022-03-01
Posted by FDA
2022-03-09
Terminated
2023-05-05
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0642-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.